gabapentin has been researched along with Bladder, Overactive in 5 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gabapentin treatment with acceptable safety profile, improves OAB symptoms and HRQOL domains." | 2.87 | Efficacy and Safety of Gabapentin in Comparison to Solifenacin Succinate in Adult Overactive Bladder Treatment. ( Balingit, JC; Chua, ME; Esmeňa, EB; Morales, ML; See, MC, 2018) |
| "Gabapentin was prescribed as an add-on therapy." | 2.78 | Gabapentin: a novel drug as add-on therapy in cases of refractory overactive bladder in children. ( Ansari, MS; Bharti, A; Kapoor, R; Kumar, R; Ranjan, P; Srivastava, A, 2013) |
| "The term OAB (overactive bladder) describes a symptom complex." | 2.55 | [Overactive bladder-which treatment when?] ( Pannek, J, 2017) |
| "In the 182 patients with chronic pain, those receiving combination therapy were more likely to respond than those taking AC alone (35." | 1.72 | Does gabapentin impact response to anticholinergics for overactive bladder? ( Alfahmy, A; Dao, A; Mitchell, D; Roberts, K; Sheyn, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roberts, K | 1 |
| Dao, A | 1 |
| Alfahmy, A | 1 |
| Mitchell, D | 1 |
| Sheyn, D | 1 |
| Yoshizumi, M | 1 |
| Watanabe, C | 1 |
| Mizoguchi, H | 1 |
| Pannek, J | 1 |
| Chua, ME | 1 |
| See, MC | 1 |
| Esmeňa, EB | 1 |
| Balingit, JC | 1 |
| Morales, ML | 1 |
| Ansari, MS | 1 |
| Bharti, A | 1 |
| Kumar, R | 1 |
| Ranjan, P | 1 |
| Srivastava, A | 1 |
| Kapoor, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Gabapentin in Treating Overactive Bladder[NCT01486706] | Phase 2/Phase 3 | 94 participants (Actual) | Interventional | 2010-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for gabapentin and Bladder, Overactive
| Article | Year |
|---|---|
[Overactive bladder-which treatment when?]
Topics: Behavior Therapy; Botulinum Toxins, Type A; Diagnosis, Differential; Electric Stimulation Therapy; F | 2017 |
2 trials available for gabapentin and Bladder, Overactive
| Article | Year |
|---|---|
Efficacy and Safety of Gabapentin in Comparison to Solifenacin Succinate in Adult Overactive Bladder Treatment.
Topics: Adolescent; Adult; Aged; Amines; Cyclohexanecarboxylic Acids; Double-Blind Method; Drug Administrati | 2018 |
Gabapentin: a novel drug as add-on therapy in cases of refractory overactive bladder in children.
Topics: Adolescent; Amines; Anticonvulsants; Child; Child, Preschool; Cholinergic Antagonists; Cyclohexaneca | 2013 |
2 other studies available for gabapentin and Bladder, Overactive
| Article | Year |
|---|---|
Does gabapentin impact response to anticholinergics for overactive bladder?
Topics: Cholinergic Antagonists; Chronic Pain; Female; Gabapentin; Humans; Neuralgia; Urinary Bladder, Overa | 2022 |
Gabapentin reduces painful bladder hypersensitivity in rats with lipopolysaccharide-induced chronic cystitis.
Topics: Analgesics; Animals; Cystitis; Cystitis, Interstitial; Disease Models, Animal; Female; Gabapentin; L | 2021 |